Therefore, in the context of obesity and hyperleptinaemia, a better understanding of the mechanisms that impair leptin-mediated adaptive thermogenesis may facilitate the development of drugs able to promote a re-sensitisation of leptin signalling, with the ultimate aim of enhancing thermogenesis, favouring body weight reduction resolving obesity-associated metabolic disorders (Table 1). Here, LEP is linked to metabolic disease.